Brunke Karen J 4

4 · CytoDyn Inc. · Filed Mar 24, 2026

AI-generated summary of this filing

Updated Mar 24, 2026

CytoDyn (CYDY) Director Karen Brunke Receives 574,385-Share Award

What Happened

Karen J. Brunke, a director of CytoDyn Inc. (CYDY), was granted an equity award reported as a derivative acquisition of 574,385 shares on March 20, 2026. The Form 4 lists the acquisition price as $0.00 and a reported value of $0 (derivative).

Key Details

Transaction date: 2026-03-20; Form filed 2026-03-24.
Reported terms: 574,385 shares @ $0.00 (derivative); listed as an award/grant (transaction code A).
Footnote F1: Grant approved by the Compensation Committee on March 20, 2026, using shares reserved under the Issuer’s 2012 Equity Incentive Plan (as amended).
Footnote F2: The stock option award vests in 12 approximately equal monthly installments, beginning April 2026 through March 2027.
Shares owned after the transaction: not specified on the provided excerpt of the filing.
Filing timeliness: no late-filing flag provided in the summary information.

Context

This was a compensatory equity award (derivative), not an open-market purchase or sale. Such awards are common as director compensation and vest over time; they do not necessarily indicate immediate buying or selling by the insider. The Form 4 reports the grant price as $0.00, which reflects how the award is recorded on the filing, not the market value of the underlying shares.

Form 4

Period: 2026-03-20

Director

Transactions

Award
Non-qualified stock option (right to buy)
[F1][F2]
2026-03-20+574,385→ 574,385 total
Exercise: $0.28Exp: 2036-03-20→ Common Stock (574,385 underlying)

Footnotes (2)

[F1]This grant was approved by the Company's Compensation Committee on March 20, 2026, and represents the annual grant to the individual for fiscal year 2026 consistent with past practice in recent years. This award was made in compliance with, and uses shares that are specifically reserved for issuance to employees, directors, and certain outside consultants under, the Issuer's 2012 Equity Incentive Plan, as amended (the "2012 Plan").
[F2]The stock option will vest in 12 approximately equal installments on the same day of each month of Continuous Service (as the term is defined in the 2012 Plan) beginning April 2026 through March 2027.

Signature

/s/ Tyler Blok, Attorney-in-Fact for Karen J Brunke|2026-03-24

1 file